Reteplase

Information about Reteplase

Reteplase uses

Reteplase is used in the treatment of heart attack.

How reteplase works

Reteplase works by dissolving the harmful blood clots in the blood vessels. This allows reperfusion of affected tissue, preventing tissue death and improving outcomes.

Common side effects of reteplase

Nausea, Vomiting, Decreased blood pressure, Injection site bleeding.

Available Medicine for Reteplase

  • ₹29750
    Lupin Ltd
    1 variant(s)
  • ₹28333
    Emcure Pharmaceuticals Ltd
    1 variant(s)
  • ₹33000
    Cipla Ltd
    1 variant(s)

Expert advice for Reteplase

  • Consult your doctor if you are suffering from any of the following: cerebrovascular disease, high blood pressure, gastrointestinal or genitourinary bleeding within 10 days, narrowing of the valves on the left side of the heart (mitral stenosis) with fast uncontrolled heartbeat (atrial fibrillation), inflammation of a vein caused by a blood clot (septic thrombophlebitis) or occluded arteriovenous cannula at seriously infected site.
  • You will be carefully evaluated for bleeding risk during treatment with reteplase.
  • Seek immediate medical advice if you feel palpitations or an irregular heartbeat after the administration of reteplase.
  • Take necessary precautions if your age is over 75 years as you are at high risk of bleeding.
  • Do not take reteplase along with heparin.
  • Stop taking reteplase and seek immediate medical attention if you develop severe allergic reaction.
  • Use of reteplase is not recommended in children.
  • Tell your doctor if you are or planning to become pregnant or are breastfeeding.

Frequently asked questions for Reteplase

Reteplase

Q. What is reteplase used for?
Reteplase is used to improve heart function and prevent congestive heart failure or death in people who have had a heart attack
Q. What is reteplase drug class?
Reteplase belongs to class of medicines called thrombolytics
Q. How does reteplase work?
Reteplase works by dissolving the blood clots (splitting of endogenous plasminogen to plasmin).

Content on this page was last updated on 08 June, 2017, by Dr. Varun Gupta (MD Pharmacology)